Drugs / ENC1018
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06224400 | Mar → Sep 2024 | — | EnnovaBio Australia Pharmaceuticals Pty Ltd | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07062185 | Jul → Aug 2025 overdue | ulcerative colitis | Tang-Du Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENC1018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07062185 ↗ |
| Route | Oral | “will be administered orally as a single dose.” NCT06224400 ↗ |